Medifast, Inc. (MED)

NYSE: MED · IEX Real-Time Price · USD
121.45
+0.97 (0.81%)
Nov 29, 2022 4:00 PM EDT - Market closed
0.81%
Market Cap 1.32B
Revenue (ttm) 1.64B
Net Income (ttm) 151.07M
Shares Out 10.96M
EPS (ttm) 13.21
PE Ratio 9.19
Forward PE n/a
Dividend $6.34 (5.22%)
Ex-Dividend Date Sep 19, 2022
Volume 104,561
Open 121.58
Previous Close 120.48
Day's Range 120.53 - 123.56
52-Week Range 96 - 222
Beta 1.20
Analysts Buy
Price Target 283.56 (+133.5%)
Earnings Date Nov 3, 2022

About MED

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecomme... [Read more]

Industry Personal Products
Founded 1980
CEO Daniel Chard
Employees 984
Stock Exchange NYSE
Ticker Symbol MED
Full Company Profile

Financial Performance

In 2021, Medifast's revenue was $1.53 billion, an increase of 63.25% compared to the previous year's $934.84 million. Earnings were $164.03 million, an increase of 59.47%.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for MED stock is "Buy." The 12-month stock price forecast is 283.56, which is an increase of 133.48% from the latest price.

Price Target
$283.56
(133.48% upside)
Analyst Consensus: Buy
Stock Forecasts

News

7 Dividend Stocks to Buy and Hold Forever

If you're looking for dividend stocks to buy and hold forever, a good place to start is companies that have done an excellent job increasing their dividends and are expected to keep doing so in the futu...

Other symbols: BCCBKEGRMNPXDTROWWSO
5 days ago - InvestorPlace

Medifast Named to the 2022 FORTUNE 100 Fastest-Growing Companies List

Company Recognized for Fourth Straight Year and is One of Only 24 Returning from the 2021 List BALTIMORE , Nov. 16, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastes...

1 week ago - PRNewsWire

Buy This Undervalued Stock Before Everyone Else Does

The average analyst 12-month price target of the nutrition and weight loss stock works out to a mind-boggling 171% upside.

3 weeks ago - The Motley Fool

Medifast (MED) Cuts View Despite Q3 Earnings Beat, Stock Down

Medifast's (MED) third-quarter 2022 results reflect reduced Coach productivity and cost inflation. Management curtails guidance.

3 weeks ago - Zacks Investment Research

Medifast Announces Third Quarter 2022 Financial Results

BALTIMORE , Nov. 3, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities,  OPTAVIA® , today reported results for the third quar...

3 weeks ago - PRNewsWire

Medifast's OPTAVIA Program Named #1 Weight Loss Program in the U.S. by Revenue for 2021*

BALTIMORE , Nov. 2, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA®, today announced it was recognized by Eurom...

3 weeks ago - PRNewsWire

Medifast's (MED) Q3 Earnings Upcoming: Things Worth Noting

Medifast's (MED) third-quarter 2022 results are likely to reflect cost-related challenges, whereas strength in the OPTAVIA lifestyle solution and coaching support system bodes well.

4 weeks ago - Zacks Investment Research

New Medifast Survey Identifies Factors Associated with Successful Long-Term Weight Loss

BALTIMORE , Oct. 24, 2022 /PRNewswire/ -- Medifast (NYSE: MED) the global company behind one of the fastest-growing health and wellness communities,  OPTAVIA ®, recently published "Healthy Habits Associ...

1 month ago - PRNewsWire

Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2022

BALTIMORE , Oct. 20, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , will announce financial results for the ...

1 month ago - PRNewsWire

These High-Yield Dividend Stocks Are Growing at Blazing Speeds

These two stocks each yield more than 5%.

Other symbols: IRM
1 month ago - The Motley Fool

Medifast Launches Free Nationwide K-5 Curriculum Promoting Healthy Habits

BALTIMORE , Sept. 22, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA ®, announced today the launch of its "Heal...

2 months ago - PRNewsWire

Losing Weight Is Losing Ground in the Stock Market

Weight-loss and nutrition companies have lost half or more of their value in the past year despite expectations of a postpandemic boom.

Other symbols: HLFWW
2 months ago - WSJ

Medifast Announces Quarterly Dividend

BALTIMORE , Sept. 8, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities,  OPTAVIA® , announced today that its Board of Direct...

2 months ago - PRNewsWire

Medifast, Inc. to Present at the Jefferies Virtual Fitness & Wellness Summit

BALTIMORE , Sept. 8, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA® , announced today that Dan Chard, Cha...

2 months ago - PRNewsWire

Why Is Medifast (MED) Down 19.8% Since Last Earnings Report?

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

Medifast (MED) Down More Than 20% in 3 Months on Cost Woes

Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.

2 months ago - Zacks Investment Research

Medifast (MED) Q2 Earnings Top Estimates, Guidance Lowered

Medifast's (MED) second-quarter 2022 results reflect increased active earning OPTAVIA Coaches and elevated costs. Management cuts guidance for 2022 due to inflation.

3 months ago - Zacks Investment Research

Medifast (MED) Surpasses Q2 Earnings Estimates

Medifast (MED) delivered earnings and revenue surprises of 17.99% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Medifast Announces Second Quarter 2022 Financial Results and Updated Outlook

BALTIMORE , Aug. 3, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities,  OPTAVIA® , today reported results for the second qua...

3 months ago - PRNewsWire

Explore DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD).

Other symbols: EXPDHSONSKYUFPI
3 months ago - Zacks Investment Research

Medifast (MED) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes?

4 months ago - Zacks Investment Research

Over 17,000 Registered for Flagship OPTAVIA Event Following Year of Rapid Growth

Immersive event dedicated to shaping the future of Optimal Health draws sold-out crowd in Atlanta BALTIMORE , July 25, 2022 /PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fas...

4 months ago - PRNewsWire

Medifast Announces New Scientific Advisory Board Appointments

Expansion of expert panel builds on company's strong scientific heritage as it sets sights on broader $230 billion health and wellness industry BALTIMORE , July 21, 2022 /PRNewswire/ -- Medifast (NYSE: ...

4 months ago - PRNewsWire

This is Why Medifast (MED) is a Great Dividend Stock

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Medifast (MED) have what it takes?

4 months ago - Zacks Investment Research

Is MEDIFAST (MED) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

4 months ago - Zacks Investment Research